Medtronic is updating the software for its SynchroMed implantable infusion pumps due to a software issue that could cause the devices to deliver too much or too little of a drug. The action is deemed ...
The FDA halted the manufacture of Medtronic's ($MDT) SynchroMed II Implantable Infusion Pump Systems, citing repeatedly failing to correct violations of the agency's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results